Girts Cimermans

Girts Cimermans

Director/Board Member at Alpcot Ltd.

Net worth: 93 222 $ as of 2024-05-30

55 year
Health Technology
Producer Manufacturing
Electronic Technology

Profile

Girts Cimermans currently works at Alpcot Ltd., as Director.
Mr. Cimermans also formerly worked at HOYA Vision Care Europe Hoya Holdings NV, as Chief Executive Officer, Hoya Vision Care, as Chief Executive Officer, medmix AG, as Chief Executive Officer from 2021 to 2024, KaVo Dental GmbH, as Director-Eastern Europe from 2009 to 2011, Sulzer AG, as President-Applicator Systems, HOYA Corp., as CO-COO, Executive Officer & Head-Life Care from 2013 to 2014, PENTAX Europe GmbH, as President-Europe Middle East & Africa from 2011 to 2013, and GE Healthcare GmbH, as President-North Eastern Europe.
Mr. Cimermans received his graduate degree from Stockholm School of Economics.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2022-12-30 5,000 ( 0.01% ) 93 222 $ 2024-05-30

Girts Cimermans active positions

CompaniesPositionStart
Director/Board Member -
All active positions of Girts Cimermans

Former positions of Girts Cimermans

CompaniesPositionEnd
MEDMIX AG Chief Executive Officer 2024-04-09
Chief Executive Officer 2012-12-31
Corporate Officer/Principal 2010-12-31
Corporate Officer/Principal -
Chief Executive Officer -
See the detail of Girts Cimermans's experience

Training of Girts Cimermans

Stockholm School of Economics Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Girts Cimermans's experience

Connections

18

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
HOYA CORPORATION

Health Technology

MEDMIX AG

Health Technology

SULZER LTD

Producer Manufacturing

Private companies6

Health Technology

Hoya Vision Care

Electronic Technology

Health Technology

Distribution Services

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Girts Cimermans